 Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Pegcetacoplan for Sale > Sichuan Duorui - Pegcetacoplan

Sichuan Duorui - Pegcetacoplan

GMP COA

Unit Price: Get Latest Price 

CAS No.:

2019171-69-6

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Chengdu

Packaging:

depends on customers' needs

Price valid (until):

2026-02-28

Contact Supplier

 Chat Now

Sichuan Duorui Biopharmaceutical Co., Ltd.

Company Type:

Manufactory

Location:

China

Payment Terms:

TT against copy of documents,L/C,100% TT in advance

Qualification:

Main Products:

Semaglutide,Tirzepatide,Retatrutide,Lanreotide Acetate,Pegcetacoplan

 Visit Store

Product Details
Seller Information
History Price

Description

Product Detail

Pegcetacoplan injection is used to treat a type of blood disease called paroxysmal nocturnal hemoglobinuria (PNH)

Pegcetacoplan is the first FDA-approved drug as a treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Please feel free to contact us if you need COA.

Contact Person：Delia Zhong

Wechat/Tel: +86 184 8235 1102

E-mail：deliazhong@duoruipharm.com

Website：https://www.duoruibiopharm.com

Certificates
Basic Info

Product Name:
Pegcetacoplan

CAS No.:
2019171-69-6

Categories:
Other Chemical Drugs
Seller Information

Business Type:
Manufactory

Main Products:
Semaglutide,Tirzepatide,Retatrutide,Lanreotide Acetate,Pegcetacoplan

Location:
No. 76 Jinle Road, Chengdu-Aba Industrial Concentration Development Zone, Jintang County, Chengdu City, Sichuan Province, China

Payment Terms:
TT against copy of documents,L/C,100% TT in advance

Total Annual Revenue:
$5 million-$10 million

Total Employees:
101-200

Year of Establishment:
2018

Established in 2018 and located in Jintang County, Chengdu, Sichuan Province, focuses on the R&D and production of peptide APIs. The company covers an area of 200,000 square meters, has a GMP production workshop, possesses advanced peptide drug preparation technology, and has large-scale peptide production capabilities, providing high-quality, low-cost, and fast-response product services.

Main products: Lanreotide Acetate, Semaglutide, Tirzepatide, Retatrutide, Teriparatide, etc.

Capacity:
Peptide for human use: 500 kg
Peptide for Veterinary use: 200 kg

Oct., 2024: "Albuvirtide" API passed the NMPA GMP compliance inspection.
Aug. 2023: "Teriparatide" Injection"assembly line passed US FDA site inspection with no 483 observation.
Weekly Price

 The chart shows the price trend of the product in the past 12 months.
Country Product Purchase Quantity Date Posted

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Supplier Name	Details
Pegcetacoplan	Pharmaceutical Grade/99	Hangzhou Fullas Pharmatech Co.,Ltd.	Inquiry
Pegcetacoplan(APL-2)	Pharmaceutical Grade/99	Shanghai WayxBio Co.,Ltd.	Inquiry
Pegcetacoplan	/	Hybio Pharmaceutical Co.,Ltd (Wuhan)	Inquiry

Sichuan Duorui - Pegcetacoplan

Product Details

Seller Information

History Price

More Choices Find All Products for Sale 

Related Searches

More from this Seller